Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
Status: Recruiting
Location: See all (9) locations...
Study Type: Observational
SUMMARY
This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
• Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).
Locations
Other Locations
Spain
Hospital Sant Rafael
COMPLETED
Barcelona
Hospital Universitario Vall d' Hebron
COMPLETED
Barcelona
Hospital Universitario de Cruces
RECRUITING
Bilbao
Policlinica Gipuzkoa Hospital
COMPLETED
Donostia / San Sebastian
MD Anderson Cancer Centre
ACTIVE_NOT_RECRUITING
Madrid
Hospital Centro Médico de Asturias
RECRUITING
Oviedo
Hospital Universitario de Salamanca
RECRUITING
Salamanca
Hospital Universitario Marques de Valdecilla
TERMINATED
Santander
Hospital Clinico Universitario Lozano Blesa
RECRUITING
Zaragoza
Contact Information
Primary
Marta Jimenez
mjimenez@amadix.com
+34637899149
Time Frame
Start Date: 2023-06-06
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 510
Treatments
Healthy
Individual with no findings or findings not related to neoplasia on colonoscopy
Advanced Adenoma
Patient diagnosed with advanced adenoma by colonoscopy and confirmed by histology result
Colorectal Cancer
Patient diagnosed with colorectal cancer by colonoscopy and confirmed by histology result
Related Therapeutic Areas
Sponsors
Leads: ADVANCED MARKER DISCOVERY S.L.